# ğŸ“ˆ Gene Expression Analysis of Drug-Resistant MCF-7 Breast Cancer Cell Lines

## ğŸ§¬ Introduction
This report explores transcriptomic changes in MCF-7 breast cancer cell lines that developed resistance to Paclitaxel (Taxolâ„¢) and Doxorubicin (Adriamycinâ„¢). Microarray expression data from drug dose experiments were analyzed to uncover potential resistance genes.

## ğŸ” Objective
Identify upregulated and downregulated genes contributing to drug resistance by analyzing gene expression data across six increasing drug doses (Dose 7â€“12), and interpret these findings in the context of cancer biology.

---

## âš™ï¸ Methodology

### Data Overview
- **Format**: `.mev` microarray files, annotated using provided annotation file.
- **Conditions**: 6 drug doses per cell line, analyzed with control (drug-naive MCF-7).
- **Software**: TMEV (for clustering, filtering, differential analysis), Excel, GeneCards.

### Analysis Steps
1. **Data Import & Normalization**
2. **Statistical Testing**: Used t-tests, ANOVA, and hierarchical clustering to identify genes with significant expression changes.
3. **Filtering**: Selected genes with consistent trends across higher doses (Doses 8â€“12).
4. **Gene Annotation & Function**: Used GeneCards for biological interpretation.

---

## ğŸ§¬ Findings

### Paclitaxel-Resistant Signature
- **Upregulated Genes**:
  - *ABCB1*: Drug efflux transporter associated with multidrug resistance.
  - *TUBB3*: Alters microtubule dynamics, interfering with Paclitaxelâ€™s mechanism.
- **Downregulated Genes**:
  - *CDKN1A*: Loss may allow unchecked cell cycle progression.

### Doxorubicin-Resistant Signature
- **Upregulated Genes**:
  - *TOP2A*: Altered expression impacts Doxorubicinâ€™s DNA intercalation target.
  - *GSTM1*: Detoxification enzyme, increases oxidative stress resistance.
- **Downregulated Genes**:
  - *TP53*: Downregulation reduces apoptotic response to DNA damage.

---

## ğŸ§  Interpretation
Resistance appears driven by multiple biological mechanisms including:
- Drug transport (efflux)
- Microtubule remodeling
- Antioxidant defense
- Apoptosis regulation

Cross-resistance patterns suggest some shared pathways in resistance evolution.

---

## ğŸ§ª Conclusion
The analysis revealed key genes implicated in acquired resistance, demonstrating complex and overlapping mechanisms. These findings reflect real-world cancer resistance challenges and highlight the value of transcriptomic profiling.

---

## ğŸ“š References
- Jordan, M. A., & Wilson, L. (2004). *Nature Reviews Cancer*, 4(4), 253â€“265.
- Gewirtz, D. A. (1999). *Biochem Pharmacol*, 57(7), 727â€“741.
- [GeneCards.org](https://www.genecards.org)

---

